Dr. Reddy's Laboratories Limited approved the appointment of Mr. K Randhir Singh with effect from March 17, 2022, as the Company Secretary and Compliance Officer of the Company Mr. Vivek Mittal, Global General Counsel of the Company, who had been appointed as an Interim Compliance Officer w.e.f. November 19, 2021, ceases to act as such with immediate effect.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,781 INR | -0.32% | -1.54% | -0.30% |
May. 21 | Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading | MT |
May. 21 | Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.30% | 11.62B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- DRREDDY Stock
- News Dr. Reddy's Laboratories Limited
- Dr. Reddy's Laboratories Limited Announces Executive Changes